Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
De Novo Germline L858R EGFR Variants and Generalized Acanthosis Nigricans.
Journal: JAMA dermatology
Published: January 14, 2026
A Novel Topical Agent for the Management of Hyperpigmentation, Including Melasma and Age Spots.
Journal: Journal of drugs in dermatology : JDD
Published: January 06, 2026
Treatment Landscape for Epidermolysis Bullosa Simplex: A Review of Established and Emerging Therapies.
Journal: Pediatric dermatology
Published: November 12, 2025
Development of a controlled ex vivo human skin platform for quantitative evaluation of age-related functional biomarkers following application of topical treatments.
Journal: Scientific reports
Published: November 11, 2025
CBL Syndrome With Granular Cell Tumor and café au lait macules: Expansion of the Phenotype.
Journal: American journal of medical genetics. Part A
Published: October 28, 2025
Intestinal failure in kaposiform hemangioendothelioma successfully resolved with medical therapy and nearly fat-free oral feeding: A novel case report.
Journal: Intestinal Failure (New York, N.Y.)
Published: October 17, 2025
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity.
Journal: JAMA dermatology
Published: October 15, 2025
Sirolimus for Venous Malformations: A Systematic Review of Efficacy and Safety.
Journal: Lymphatic research and biology
Published: September 10, 2025
Mesenchymal stromal cell therapy in epidermolysis bullosa: current perspectives and future directions.
Journal: Frontiers in cell and developmental biology
Published: September 10, 2025
Managing Rosacea with Nanodiamond-zinc Oxide: Real-world Evidence for Reduction in Redness and Acne Lesions.
Journal: The Journal of clinical and aesthetic dermatology
Published: August 08, 2025
Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure.
Journal: British journal of clinical pharmacology
Published: August 05, 2025
Last Updated: 09/26/2026